EPIGENETIC REGULATION OF ROR1 IN CHRONIC LYMPHOCYTIC LEUKEMIA DEFINES PREFERABLE TARGET FOR COMBINED EPIGENETIC AND IMMUNE THERAPY

被引：0
|
作者：
Skorka, K. [1 ]
Karp, M. [1 ]
Zakrzewska, E. [1 ]
Zaleska, J. [1 ]
Zajac, M. [1 ]
Karczmarczyk, A. [1 ]
Purkot, J. [1 ]
Tomczak, W. [2 ]
Wlasiuk, P. [1 ]
Matosiuk, D. [3 ]
Giannopoulos, K. [1 ,4 ]
机构：
[1] Med Univ Lublin, Dept Expt Hematooncol, Lublin, Poland
[2] Med Univ Lublin, Dept Hematooncol & Bone Marrow Transplantat, Lublin, Poland
[3] Med Univ Lublin, Dept Synth & Technol Pharmaceut Subst, Lublin, Poland
[4] St Johns Canc Ctr, Dept Hematooncol 3, Lublin, Poland
来源：
HAEMATOLOGICA | 2016年 / 101卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
P584
引用
收藏
页码：224 / 224
页数：1
相关论文
共 50 条
  • [31] Evaluation of ROR1 Targeted Antibody Drug Conjugates in Acute and Chronic Lymphocytic Leukemia and Mantle Cell Lymphoma
    Hu, Eileen
    Do, Priscilla
    Mani, Rajeswaran
    Frissora, Frank
    Peng, Haiyong
    Waldmeier, Lorenz
    Beerli, Roger
    Rader, Christoph
    Grawunder, Ulf
    Byrd, John C.
    Muthusamy, Natarajan
    BLOOD, 2017, 130
  • [32] Phase I Trial: Cirmtuzumab Inhibits ROR1 Signaling and Stemness Signatures in Patients with Chronic Lymphocytic Leukemia
    Choi, Michael Y.
    Widhopf, George F., II
    Ghia, Emanuela M.
    Kidwell, Reilly L.
    Hasan, Md Kamrul
    Yu, Jian
    Rassenti, Laura Z.
    Chen, Liguang
    Chen, Yun
    Pittman, Emily
    Pu, Minya
    Messer, Karen
    Prussak, Charles E.
    Castro, Januario E.
    Jamieson, Catriona
    Kipps, Thomas J.
    CELL STEM CELL, 2018, 22 (06) : 951 - +
  • [33] Expression of ROR1 in chronic lymphocytic leukemia cells enhances cells survival by Wnt5a signaling
    Chen, Liguang
    Tang, Li
    Fukuda, Tetsu
    Kipps, Thomas J.
    BLOOD, 2007, 110 (11) : 107A - 107A
  • [34] Receptor tyrosine kinase-like orphan receptor 1 (ROR1) as a potential target antigen for immunotherapy of human B cell chronic lymphocytic leukemia
    Baskar, Sivasubramanian
    Kwong, Ka Yin
    Hofer, Thomas
    Levy, Jessica M.
    Kennedy, Michael G.
    Wilson, Wyndham H.
    Wiestner, Adrian
    Rader, Christoph
    JOURNAL OF IMMUNOTHERAPY, 2006, 29 (06) : 671 - 672
  • [35] LYL797, a ROR1 CAR T-cell therapy with genetic and epigenetic reprogramming for solid tumors
    Park, Spencer
    Simianer, Courtney
    Spadinger, Sydney
    Wang, Xiao
    Sundar, Purnima
    Potluri, Shobha
    Lynn, Rachel
    Boldajipour, Bijan
    Wang, Grace
    Sharma, Neeraj
    Hiraragi, Hajime
    Krishnamoorthy, Veena
    Vodnala, Suman Kumar
    Ong, E-Ching
    Wu, Chang-Chih
    Wohlfahrt, Martin
    Ryu, Byoung
    Song, Lisa
    Weitzner, Brian D.
    Moffett, Howell
    Lajoie, Marc
    Boyken, Scott
    Shabaneh, Tamer
    Srivastava, Shivani
    Albertson, Tina
    Sather, Blythe
    CANCER RESEARCH, 2022, 82 (12)
  • [36] A B-CELL EPIGENETIC SIGNATURE DEFINES THREE BIOLOGICAL SUBGROUPS OF CHRONIC LYMPHOCYTIC LEUKEMIA WITH MAJOR CLINICAL IMPACT
    Queiros, A. C.
    Villamor, N.
    Martinez-Trillos, A.
    Kulis, M.
    Clot, G.
    Navarro, A.
    Penas, E. M. Murga
    Jayne, S.
    Majid, A.
    Richter, J.
    Bergmann, A. K.
    Kolarova, J.
    Royo, C.
    Russinol, N.
    Castellano, G.
    Pinyol, M.
    Bea, S.
    Salaverria, I.
    Lopez-Guerra, M.
    Aymerich, M.
    Rozman, M.
    Colomer, D.
    Delgado, J.
    Gine, E.
    Gonzalez-Diaz, M.
    Puente, X. S.
    Siebert, R.
    Dyer, M. J.
    Rozman, C.
    Lopez-Otin, C.
    Campo, E.
    Lopez-Guillermo, A.
    Martin-Subero, J. I.
    HAEMATOLOGICA, 2014, 99 : 52 - 52
  • [37] Wnt5a induces ROR1 to complex with HS1 to enhance migration of chronic lymphocytic leukemia cells
    Hasan, M. K.
    Yu, J.
    Chen, L.
    Cui, Bing
    Widhopf, G. F., II
    Rassenti, L.
    Shen, Z.
    Briggs, S. P.
    Kipps, T. J.
    LEUKEMIA, 2017, 31 (12) : 2615 - 2622
  • [38] Wnt5a causes ROR1 to complex and activate cortactin to enhance migration of chronic lymphocytic leukemia cells
    Md Kamrul Hasan
    Laura Rassenti
    George F. Widhopf
    Jian Yu
    Thomas J. Kipps
    Leukemia, 2019, 33 : 653 - 661
  • [39] Venetoclax resistance associates with high-level expression of ROR1 and cancer stemness in chronic lymphocytic leukemia.
    Ghia, Emanuela M.
    Rassenti, Laura Z.
    Choi, Michael Y.
    Quijada-Alamo, Miguel
    Chu, Elvin
    Widhopf, George F.
    Kipps, Thomas J.
    CANCER RESEARCH, 2021, 81 (13)
  • [40] Wnt5a induces ROR1 to complex with HS1 to enhance migration of chronic lymphocytic leukemia cells
    M K Hasan
    J Yu
    L Chen
    Bing Cui
    G F Widhopf II
    L Rassenti
    Z Shen
    S P Briggs
    T J Kipps
    Leukemia, 2017, 31 : 2615 - 2622
12345